Monophosphoryl lipid A data

RIBI (Hamilton, Mont.) announced that Phase II data presented by SmithKline Beecham at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) showed enhanced quality and duration of the immune response.

The vaccine is recombinant, truncated herpes virus type 2 glycoprotein D. ...